Citadel Advisors - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 156 filers reported holding CONMED CORP in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$10,148,233
-70.3%
100,627
-60.0%
0.00%
-57.1%
Q2 2023$34,144,809
+653.3%
251,268
+475.8%
0.01%
+600.0%
Q1 2023$4,532,450
-89.2%
43,640
-90.8%
0.00%
-90.0%
Q4 2022$41,926,898
+220.0%
473,002
+189.4%
0.01%
+233.3%
Q3 2022$13,102,000
+46.1%
163,425
+74.5%
0.00%
+50.0%
Q2 2022$8,970,000
-67.9%
93,675
-50.2%
0.00%
-66.7%
Q1 2022$27,956,000
+293.8%
188,186
+275.8%
0.01%
+200.0%
Q4 2021$7,099,000
-65.1%
50,081
-67.8%
0.00%
-50.0%
Q3 2021$20,340,000
+8.3%
155,474
+13.8%
0.00%0.0%
Q2 2021$18,779,000
+6.4%
136,643
+1.1%
0.00%0.0%
Q1 2021$17,648,000
+153.6%
135,136
+117.5%
0.00%
+100.0%
Q4 2020$6,960,000
+188.9%
62,144
+102.9%
0.00%
+100.0%
Q3 2020$2,409,000
-22.4%
30,621
-29.0%
0.00%0.0%
Q2 2020$3,106,000
-27.6%
43,140
-42.4%
0.00%
-50.0%
Q1 2020$4,288,000
-27.1%
74,875
+42.3%
0.00%0.0%
Q4 2019$5,885,000
-42.9%
52,628
-50.9%
0.00%
-50.0%
Q3 2019$10,308,000
+101.2%
107,199
+79.0%
0.00%
+100.0%
Q2 2019$5,123,000
-73.3%
59,874
-74.0%
0.00%
-77.8%
Q1 2019$19,161,000
+590.0%
230,362
+432.6%
0.01%
+350.0%
Q4 2018$2,777,000
-80.2%
43,249
-75.6%
0.00%
-66.7%
Q3 2018$14,042,000
+30.5%
177,264
+20.6%
0.01%
+20.0%
Q2 2018$10,761,000
+4881.9%
147,015
+4203.7%
0.01%
Q1 2018$216,000
-87.9%
3,416
-90.2%
0.00%
-100.0%
Q4 2017$1,780,000
+638.6%
34,921
+661.1%
0.00%
Q3 2017$241,000
-80.6%
4,588
-81.2%
0.00%
-100.0%
Q2 2017$1,243,000
-62.2%
24,404
-67.1%
0.00%
-66.7%
Q1 2017$3,292,000
+262.2%
74,127
+260.3%
0.00%
+200.0%
Q4 2016$909,000
-79.3%
20,571
-81.2%
0.00%
-75.0%
Q3 2016$4,391,000
+1440.7%
109,604
+1738.7%
0.00%
Q2 2016$285,000
-52.8%
5,961
-56.5%
0.00%
-100.0%
Q4 2015$604,000
-47.8%
13,716
-43.4%
0.00%0.0%
Q3 2015$1,156,000
+1091.8%
24,226
+1349.8%
0.00%
Q2 2015$97,000
-64.5%
1,671
-69.1%
0.00%
Q1 2015$273,000
+225.0%
5,415
+191.0%
0.00%
Q4 2014$84,000
+90.9%
1,861
+54.7%
0.00%
Q3 2014$44,000
-99.0%
1,203
-98.8%
0.00%
-100.0%
Q2 2014$4,371,000
+86.0%
99,001
+83.1%
0.01%
+66.7%
Q1 2014$2,350,000
+349.3%
54,077
+339.2%
0.00%
+200.0%
Q4 2013$523,000
-32.1%
12,314
-45.6%
0.00%0.0%
Q3 2013$770,00022,6440.00%
Other shareholders
CONMED CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders